Please check your internet connection and try again.
# Ecospirin (Aspirin Enteric-Coated)
## Overview
Ecospirin is an enteric-coated formulation of aspirin, a nonsteroidal anti-inflammatory drug (NSAID) with analgesic, antipyretic, and antiplatelet properties. The enteric coating is designed to delay the absorption of aspirin until it reaches the small intestine, which may reduce gastric irritation.
## Primary Indications
* **Cardiovascular prophylaxis:** To reduce the risk of myocardial infarction, stroke, and cardiovascular death in patients with established cardiovascular disease or risk factors.
* **Pain and inflammation:** For mild to moderate pain and inflammatory conditions (less common with enteric-coated formulations due to delayed onset).
## Adult Dosing
* **Cardiovascular prophylaxis:**
* **Primary prevention:** 75-100 mg once daily. The decision for primary prevention should be individualized based on cardiovascular risk assessment and bleeding risk.
* **Secondary prevention:** 75-325 mg once daily. Higher doses (e.g., 325 mg) may be used initially after acute events like myocardial infarction or stroke, then reduced to a maintenance dose.
* **Pain and inflammation:** Doses vary widely depending on the condition. For mild to moderate pain, doses typically range from 325 mg to 650 mg every 4-6 hours as needed. Maximum daily dose for pain/inflammation is generally 4000 mg, but lower doses are preferred for chronic use to minimize risk.
## Pediatric Dosing
Aspirin is generally **contraindicated** in children and adolescents with viral infections (e.g., influenza, varicella) due to the risk of Reye's syndrome. When aspirin is indicated in pediatric populations for specific conditions like Kawasaki disease, dosing is typically weight-based and guided by specialist recommendations.
## Dose Adjustments
No specific dose adjustments are typically required for renal or hepatic impairment, but caution is advised. Aspirin is renally excreted, and high doses or chronic use can precipitate renal issues, especially in patients with pre-existing renal disease.
## Contraindications
* Hypersensitivity to aspirin, NSAIDs, or salicylates.
* History of bronchospasm, asthma, urticaria, or allergic-type reactions after aspirin or NSAID administration.
* Active peptic ulceration or gastrointestinal bleeding.
* Certain bleeding disorders (e.g., hemophilia).
* In children and adolescents with viral infections (risk of Reye's syndrome).
## Adverse Effects
* **Gastrointestinal:** Dyspepsia, heartburn, nausea, abdominal pain, GI bleeding, ulceration. Enteric coating reduces but does not eliminate risk.
* **Hemorrhagic:** Increased bleeding time, bruising, epistaxis, petechiae.
* **Hypersensitivity:** Bronchospasm, urticaria, angioedema.
* **Other:** Tinnitus (especially at higher doses), dizziness, headache.
## Key Drug Interactions
* **Anticoagulants (e.g., warfarin, heparin, DOACs):** Increased risk of bleeding.
* **Other NSAIDs and COX-2 inhibitors:** Increased risk of GI toxicity and bleeding.
* **Corticosteroids:** Increased risk of GI ulceration and bleeding.
* **Antihypertensives:** May reduce the efficacy of some antihypertensive agents.
* **Methotrexate:** Increased methotrexate toxicity due to decreased renal clearance.
* **Uricosuric agents (e.g., probenecid):** Aspirin may antagonize the uricosuric effect.
## Monitoring
* **Signs of GI bleeding:** Melena, hematemesis, abdominal pain.
* **Signs of bleeding:** Easy bruising, prolonged bleeding from cuts, epistaxis.
* **Renal function:** Especially with chronic use or in patients with risk factors.
* **Tinnitus:** May indicate toxicity, particularly at higher doses.
## Clinical Pearls
* The enteric coating of Ecospirin is intended to be swallowed whole and **should not be crushed, chewed, or broken**.
* While the enteric coating reduces gastric irritation, it does not eliminate the risk of GI bleeding or ulceration, especially with long-term use or in susceptible individuals.
* For acute cardiovascular events (e.g., STEMI), non-enteric coated immediate-release aspirin is generally preferred for faster absorption.
* The antiplatelet effect of aspirin is irreversible and lasts for the life of the platelet (7-10 days).
***
**Disclaimer:** This information is intended for clinical decision support and does not replace professional medical judgment. Always consult the most current prescribing information and relevant clinical guidelines before making therapeutic decisions. Dosing may vary based on specific patient factors and local protocols.
